Integration of Metabolomics and Transcriptomics Reveals the Therapeutic Mechanism Underlying Paeoniflorin for the Treatment of Allergic Asthma

Shou, Qiyang; Jin, Lu; Lang, Jiali; Shan, Qiyuan; Ni, Zhunan; Cheng, Changpei; Li, Qinglin; Fu, Huiying; Cao, Gang

doi:10.3389/fphar.2018.01531

Cited by 33 publications

(20 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…3A,B).We found that most of genes were related to the response to immune, Cancer immunotherapy is a breakthrough in cancer, such as cytokine therapy [34]. previous articles have con rmed the in ammation and immunity of paeoni orin in diseases such as rheumatoid [38], allergic asthma [39] and arthritis [40]. In addition, the GO analysis results also explain that paeoni orin is also involved in cell migration [17,41], cell activation, and cell activity regulation.…”

Section: Discussionmentioning

confidence: 54%

Analysis of Paeoniflorin Treatment of Cancer Based on Bioinformatic Network and Potential Target Prediction

yongan¹,

Yu²,

Li³

et al. 2020

Preprint

View full text Add to dashboard Cite

In the synthesis of chemical drugs used to treat various cancers and tumors,more and more scientists are now focusing on the development of natural extracts.Paeoniflorin,as an important compounds of the total glucosides of peony,,had therapeutic effects on a variety of cancers in vivo and in vitro experiments.The purpose of this study was to use biological information analysis to reveal the basic mechanism and potential molecular mechanism of paeoniflorin treatment.We evaluated the efficacy of paeoniflorin through Traditional Chinese Medicine Systems Pharmacology Database(TCMSP).The potential targets of paeoniflorin were identified and summarized by Comparative Toxicogenomics Database (CTD),and GeneMANIA protein interaction analysis was performed online.Also.We used WebGestalt for Gene Ontology(GO) analysis and Kyoto Encyclopedia of Genes and Genomes(KEGG) analysis and functional annotation.Finally,cytoscape was used to construct the paeoniflorin-target-pathway network to predict the results.

show abstract

Section: Discussionmentioning

confidence: 54%

Analysis of Paeoniflorin Treatment of Cancer Based on Bioinformatic Network and Potential Target Prediction

yongan¹,

Yu²,

Li³

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…MetScape 3 may be used to visualize and interpret metabolomics and gene expression profiling data in an integrated metabolic network ( 28 , 30 ). To investigate the correlation of metabolites and gene expression affected by asarum treatment, metabolite and gene expression profiles were imported into the Cytoscape for Metscape analysis.…”

Section: Resultsmentioning

confidence: 99%

Integrative transcriptomics and metabolomics analyses provide hepatotoxicity mechanisms of asarum

Cao

Han²,

et al. 2020

Exp Ther Med

View full text Add to dashboard Cite

Asarum is frequently applied in combination with other agents for prescriptions in practices of Traditional Chinese Medicine. A number of studies have previously indicated that asarum treatment induces lung toxicity by triggering inflammation. However, the potential effects of asarum in the liver and the underlying mechanisms have remained largely elusive. Therefore, transcriptomics and metabolomics approaches were used in the present study to examine the mechanisms of the hepatotoxicity of asarum. Specifically, mRNA and metabolites were obtained from rat liver samples following intragastric administration of asarum powder. RNA sequencing analysis was subsequently performed to screen for differentially expressed genes (DEGs), and a total of 434 DEGs were identified in liver tissue samples, 214 of which were upregulated and 220 were downregulated. Pathway enrichment analysis found that these genes were particularly enriched in processes including the regulation of p53 signaling, metabolic pathways and bile secretion. To investigate potential changes to the metabolic profile as a result of asarum treatment, a metabolomics analysis was performed, which detected 14 significantly altered metabolites in rat liver samples by gas chromatography-mass spectrometry. These metabolites were predominantly members of the taurine, hypotaurine and amino acid metabolic pathways. Metscape network analyses were subsequently performed to integrate the transcriptomics and metabolomics data. Integrative analyis revealed that the DEGs and metabolites were primarily associated with bile acid biosynthesis, amino acid metabolism and the p53 signaling pathway. Taken together, these results provide novel insight into the mechanism of asarum-mediated hepatotoxicity, which may potentially aid the clinical diagnosis and future therapeutic intervention of asarum poisoning.

show abstract

“…on diverse diseases such as rheumatoid arthritis, liver fibrosis, chronic heart failure, and asthma. [19][20][21][22] However, its efficacy against the development and progression of PAH has never been tested. In the present study, we found that paeoniflorin significantly ameliorated SU5416/hypoxia-induced PAH and reduced pulmonary vascular remodeling and right ventricular hypertrophy.…”

Section: Discussionmentioning

confidence: 99%

<p>Paeoniflorin Ameliorates Chronic Hypoxia/SU5416-Induced Pulmonary Arterial Hypertension by Inhibiting Endothelial-to-Mesenchymal Transition</p>

Yu¹,

Peng²,

Liu³

et al. 2020

DDDT

View full text Add to dashboard Cite

Background: Endothelial cells dysfunction is one of the hallmark pathogenic features of pulmonary arterial hypertension (PAH). Paeoniflorin (PF) is a monoterpene glycoside with endothelial protection, vasodilation, antifibrotic, anti-inflammatory and antioxidative properties. However, the effects of PF on PAH remain unknown. Methods: Here, we investigated the efficacy of PF in the SU5416/hypoxia (SuHx) rat model of PAH. Human pulmonary arterial endothelial cells (HPAECs) were exposed to 1% O 2 with or without PF treatment. Results: Hemodynamics analysis showed that prophylactic treatment with PF (300 mg/kg i.g. daily for 21 days) significantly inhibited chronic hypoxia/SU5416-induced elevations of right ventricular systolic pressure (RVSP) and right ventricular hypertrophy index in rats. Meanwhile, PF significantly reduced pulmonary vascular remodeling, as well as alleviated collagen deposition in lungs and right ventricles in SuHx rats. Additionally, PF inhibited SuHx-induced down-regulation of endothelial marker (vascular endothelial cadherin) and upregulation of mesenchymal markers (fibronectin and vimentin) in lung, suggesting that PF could inhibit SuHx-induced endothelial-to-mesenchymal transition (EndMT) in lung. Further in vitro studies confirmed that PF treatment suppressed hypoxia-induced EndMT in HPAECs, which was abolished by the knockdown of bone morphogenetic protein receptor type 2 (BMPR2) in HPAECs. Conclusion: Taken together, our findings suggest that PF ameliorates BMPR2 downregulation-mediated EndMT and thereafter alleviates SuHx-induced PAH in rats.

show abstract

Integration of Metabolomics and Transcriptomics Reveals the Therapeutic Mechanism Underlying Paeoniflorin for the Treatment of Allergic Asthma

Cited by 33 publications

References 34 publications

Analysis of Paeoniflorin Treatment of Cancer Based on Bioinformatic Network and Potential Target Prediction

Analysis of Paeoniflorin Treatment of Cancer Based on Bioinformatic Network and Potential Target Prediction

Integrative transcriptomics and metabolomics analyses provide hepatotoxicity mechanisms of asarum

<p>Paeoniflorin Ameliorates Chronic Hypoxia/SU5416-Induced Pulmonary Arterial Hypertension by Inhibiting Endothelial-to-Mesenchymal Transition</p>

Contact Info

Product

Resources

About